<DOC>
	<DOCNO>NCT02089061</DOCNO>
	<brief_summary>This purpose study assess effect BMS-919373 single dose Pharmacokinetics ( PK ) Rosuvastatin Atorvastatin healthy subject .</brief_summary>
	<brief_title>Drug Interaction Statin</brief_title>
	<detailed_description>Primary Purpose : Other - To assess effect BMS-919373 single dose PK Rosuvastatin Atorvastatin healthy subject</detailed_description>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com . Signed Written Informed Consent form Healthy subject determine clinically significant deviation normal medical surgical history , physical examination , physical measurement , vital sign , 12lead ECG , 24hour telemetry , clinical laboratory test Body mass index ( BMI ) 18.0 32.0 kg/m2 , inclusive Men woman , age 18 55 yr , inclusive Current history cardiovascular disease , include arrhythmia , coronary heart disease , congestive heart failure Current history symptomatic hypotension Current history liver disease , include cirrhosis liver failure Current history kidney disease , include nephrotic syndrome , renal failure , nephrolithiasis , urolithiasis Current history neurological disease , include presyncope , syncope , convulsive disorder epilepsy , cerebral thrombosis cerebral embolism , transient ischemic attack , stroke ; mental disorder Exceptions presyncope/syncope relate vasovagal response allowable discretion investigator History significant head injury last 2 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>